3. Umbruch 4.4..2005 - Online Pot

Cannabis in India: ancient lore and modern medicine 21
90 Metz L, Page S (2003) Oral cannabinoids for spasticity in multiple sclerosis: will attitude continue
to limit use? Lancet 362: 1513
91 Hampson AJ, Grimaldi M, Axelrod J, Wink D (1998) Cannabidiol and (–)Delta9-tetrahydrocannabinol
are neuroprotective antioxidants. Proc Natl Acad Sci USA 95: 8268–8273
92 Russo E (1998) Cannabis for migraine treatment: The once and future prescription? An historical
and scientific review. Pain 76: 3–8
93 Russo EB (2001) Hemp for headache: An in-depth historical and scientific review of cannabis in
migraine treatment. J Cannabis Therapeutics 1: 21–92
94 Mechoulam R (1986) The pharmacohistory of Cannabis sativa. In: R Mechoulam (ed.):
Cannabinoids as therapeutic agents. CRC Press, Boca Raton, FL, 1–19
95 Carlini EA, Cunha JM (1981) Hypnotic and antiepileptic effects of cannabidiol. J Clin
Pharmacol 21: 417S–427S
96 Wallace MJ, Blair RE, Falenski KW, Martin BR, DeLorenzo RJ (2003) The endogenous cannabinoid
system regulates seizure frequency and duration in a model of temporal lobe epilepsy. J
Pharmacol Exp Ther 307: 129–137
97 Wallace MJ, Martin BR, DeLorenzo RJ (2002) Evidence for a physiological role of endocannabinoids
in the modulation of seizure threshold and severity. Eur J Pharmacol 452: 295–301
98 Leonardi CL, Powers JL, Matheson RT, Goffe BS, Zitnik R, Wang A, Gottlieb AB (2003)
Etanercept as monotherapy in patients with psoriasis. N Engl J Med 349: 2014–2022
99 Malfait AM, Gallily R, Sumariwalla PF, Malik AS, Andreakos E, Mechoulam R, Feldmann M
(2000) The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic
in murine collagen-induced arthritis. Proc Natl Acad Sci USA 97: 9561–9566
100 Richardson JD, Kilo S, Hargreaves KM (1998) Cannabinoids reduce hyperalgesia and inflammation
via interaction with peripheral CB1 receptors. Pain 75: 111–119
101 Abrams DI, Hilton JF, Leiser RJ, Shade SB, Elbeik TA, Aweeka FT, Benewitz NL, Bredt BM,
Kosel B, Aberg JA et al. (2003) Short-term effects of cannabinoids in patients with HIV-1 infection.
A randomized, placbo-controlled clinical trial. Ann Intern Med 139: 258–266
102 Abrahamov A, Mechoulam R (1995) An efficient new cannabinoid antiemetic in pediatric oncology.
Life Sci 56: 2097–2102
103 Musty RE, Rossi R (2001) Effects of smoked cannabis and oral delta-9-tetrahydrocannabinol on
nausea and emesis after cancer chemotherapy: A review of state clinical trials. J Cannabis
Therapeutics 1: 29–42
104 Guzman M (2003) Cannabinoids: potential anticancer agents. Nat Rev Cancer 3: 745–755
105 Maccarrone M, Finazzi-Agro A (2003) The endocannabinoid system, anandamide and the regulation
of mammalian cell apoptosis. Cell Death Differ 10: 946–955
106 De Petrocellis L, Melck D, Palmisano A, Bisogno T, Laezza C, Bifulco M, Di Marzo V (1998)
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proc
Natl Acad Sci USA 95: 8375–8380
107 Roth MD, Marques-Magallanes JA, Yuan M, Sun W, Tashkin DP, Hankinson O (2001) Induction
and regulation of the carcinogen-metabolizing enzyme CYP1A1 by marijuana smoke and delta
(9)-tetrahydrocannabinol. Am J Respir Cell Mol Biol 24: 339–344
108 Williams SJ, Hartley JP, Graham JD (1976) Bronchodilator effect of delta1-tetrahydrocannabinol
administered by aerosol of asthmatic patients. Thorax 31: 720–723
109 Falk AA, Hagberg MT, Lof AE, Wigaeus-Hjelm EM, Wang ZP (1990) Uptake, distribution and
elimination of alpha-pinene in man after exposure by inhalation. Scand J Work Environ Health
16: 372–378
110 Pertwee RG, Ross RA (2002) Cannabinoid receptors and their ligands. Prostaglandins Leukot
Essent Fatty Acids 66: 101–121
111 McPartland JM, Russo EB (2001) Cannabis and cannabis extracts: Greater than the sum of their
parts? J Cannabis Therapeutics 1: 103–132
112 Pertwee RG (2001) Cannabinoids and the gastrointestinal tract. Gut 48: 859–867
113 Wright K, Rooney N, Tate J, Feeney M, Robertson D, Welham M, Ward S (2003) Functional
cannabinoid receptor expression in human colonic epithelium. In: 2003 Symposium on the
Cannabinoids. International Cannabinoid Research Society, Cornwall, ON, Canada, 25
114 Douthwaite AH (1947) Choice of drugs in the treatment of duodenal ulcer. Brit Med J 2: 43–47
115 Tambe Y, Tsujiuchi H, Honda G, Ikeshiro Y, Tanaka S (1996) Gastric cytoprotection of the
non-steroidal anti-inflammatory sesquiterpene, beta-caryophyllene. Planta Med 62: 469–470
116 Schnelle M, Grotenhermen F, Reif M, Gorter RW (1999) [Results of a standardized survey on the